Hyperfine, Inc. the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance (MR) brain imaging system—the Swoop® system—announced that the first patients have been enrolled in the CARE PMR (Capturing ARIA Risk Equitably with Portable MR) observational study.
Omnicell, Inc. a leader in transforming the pharmacy care delivery model, announced XT Amplify, a multi-year innovation program that is intended to maximize value for hospitals, health systems, and post-acute care facilities that have invested in Omnicell’s XT Automated Dispensing System while also seeking to drive enhanced clinical and operational outcomes at the points of care and within pharmacies.
Babson Diagnostics, a science-first healthcare technology company,announced the newest innovation in its BetterWay™ blood testing ecosystem has completed validation testing. The company created a unique hand-warming technology specifically designed to support the collection of high-quality blood samples from a fingertip.
Centinel Spine®, LLC ("the Company"), the leading global medical device company focused exclusively on treating cervical and lumbar spinal disease with the most complete and clinically-proven total disc replacement (TDR) technology platform in the world (prodisc®), announced the completion of the 5,000th case in the U.S. with the prodisc C Vivo and prodisc C SK Cervical TDR System.
4WEB Medical, an orthopedic implant company focused on developing innovative implants that utilize its proprietary Truss Implant Technology™, announced the full commercial launch of the newest addition to the company's implant portfolio, the Cervical Spine Plating Solution (CSTS-PS).
Acclaro Medical proudly announces new clinical study results on nasal contouring, acne scarring, facial resurfacing, facial and neck rejuvenation with stem cell extract and UltraClear® Laser-Coring™ will be presented at the American Society for Laser Medicine and Surgery (ASLMS) global conference, to be held April 11-14, 2024 in Baltimore, MD.
Smith+Nephew the global medical technology company, announces the review of medical technologies guidance from the UK National Institute for Health and Care Excellence (NICE) for its PICO Single Use Negative Pressure Wound Therapy System (sNPWT).
Medline and Consure Medical announced a new agreement for Medline to exclusively distribute the QiVi® MEC male external urine management device to help guard against catheter-associated urinary tract infections (CAUTI) and incontinence-associated dermatitis (IAD).
Guardant Health Inc, a leading precision oncology company, announced that results from the ECLIPSE study showing the effectiveness of its ShieldTM blood test for detecting colorectal cancer (CRC) in average-risk adults will be published in the March 14 issue of The New England Journal of Medicine.
Medline, a market-leading manufacturer and supplier of medical supplies and solutions, announced the successful acquisition of the manufacturing rights and intellectual property of AG Cuffill from Hospitech Respiration Ltd. The compact and intuitive syringe-like device provides an accurate solution for measuring both pressure and volume of airway cuffs in all clinical settings.